In our cohort, the majority of patients were found to have elevated ESR and CRP (86.4% and 59.1%, respectively), which were significantly higher than those in the IgG4-RD-non-RPF group. The gene discussed is CRP; the disease is immunoglobulin G4-related sclerosing disease.